Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 403
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04578106 | Omission of Surgery in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti-HER2-based Neoadjuvant Therapy | ||
| NCT00495547 | SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome | ||
| NCT01384838 | Exercise Training in Postmenopausal Patients With Breast Cancer | ||
| NCT01524679 | Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen | ||
| NCT01066689 | Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation | ||
| NCT05038657 | Atezolizumab Immunotherapy, in Immunotherapy Naive Patients With Urinary Tract Squamous Cell Carcinoma (UTSCC). | ||
| NCT04363853 | Tocilizumab Treatment in Patients With COVID-19 | ||
| NCT00476996 | A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) | ||
| NCT02569736 | Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation | ||
| NCT01565200 | HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1 | ||
| NCT04984811 | NT-I7 in Combination With Atezolizumab in Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC | ||
| NCT01306409 | Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA) | ||
| NCT02012634 | Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer | ||
| NCT05529524 | Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL) | ||
| NCT01745965 | A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol. | ||
| NCT01259856 | Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) | ||
| NCT00203606 | Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C | ||
| NCT00440167 | Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of Capecitabine | ||
| NCT00484328 | Ribavirin, Its Dosing Regime | ||
| NCT03784599 | T-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive NSCLC | ||
| NCT04497285 | Real World Study Using Comprehensive Genomic Data on the Next Treatment Decision Making in Metastatic Breast Cancer | ||
| NCT00483405 | Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer | ||
| NCT00273767 | Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB | ||
| NCT00973609 | Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC) | ||
| NCT00223301 | Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis | ||
| NCT02914470 | Carboplatin-cyclophosphamide Combined With Atezolizumab | ||
| NCT01523340 | A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response | ||
| NCT01259817 | Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) | ||
| NCT05293015 | NP-Supported Multidisciplinary Diabetes Management During Perioperative Period | ||
| NCT00612586 | Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer | ||
| NCT00205556 | Effect of Increased Convective Clearance by On-Line Hemodiafiltration on All Cause Mortality in Chronic Hemodialysis Patients | ||
| NCT05802836 | Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab | ||
| NCT05798312 | Randomized and Multicenter Study to Evaluate a Customizable Support Breast Cancer Material | ||
| NCT03046381 | Tocilizumab in Patients With Schnitzler's Syndrome | ||
| NCT04770272 | Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy with Atezolizumab - CTX Therapy | ||
| NCT00374036 | Metastatic Gastric Cancer FFCD 03-07 | ||
| NCT06634225 | Use of Inertial Units in Patient With Multiple Sclerosis (IMUSEP) | ||
| NCT00316420 | Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer | ||
| NCT05300282 | Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients | ||
| NCT03385668 | Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies | ||
| NCT00262717 | Can Resistance Enhance Selection of Treatment? (CREST) | ||
| NCT05825261 | Exploring Novel Biomarkers for Emphysema Detection | ||
| NCT00275132 | Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT04059081 | A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assessment | ||
| NCT00730769 | Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients | ||
| NCT00738829 | Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL | ||
| NCT00335595 | Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients | ||
| NCT04759248 | Study With Atezolizumab in Combination With Trastuzumab and Vinorelbine in HER2-positive Advanced/Metastatic Breast Cancer | ||
| NCT04400474 | Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study | ||
| NCT01660776 | BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology |
